Abstract
In this chapter we will consider diseases in which malformations, functional abnormalities or inflammation of the arteries, arterioles, capillaries, venules and veins play a major role. A certain amount of overlap with other chapters is unavoidable. Some vascular malformations are considered under nevi (Chap. 52), while the role of the vessels is also emphasized in allergic reactions (Chap. 11).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliography
Hereditary Hemorrhagic Telangiectasia
Babington BG (1865) Hereditary epistaxis 2:362–363
Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333(14): 918–924
Haitjema T, Westermann CJ, Overtoom TT et al. (1996) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 156 (7): 714–719
Harries PG, Brockbank MJ, Shakespeare PG et al. (1997) Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser. J Laryngol Otol 111:1038–1041
Osler W (1907) On multiple hereditary telangiectases with recurrent hemorrhage. Q J Med 1:53–58
Rendu H (1896) Epistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Soc Méd Hôp, Paris 13:731–733
Rius C, Smith JD, Almendro N et al. (1998) Cloning of the promotor region of human endoglin, the target gene for hereditary hemorrhagic telangiectasia type 1. Blood 92: 4677–4690
Shovlin CL (1997) Molecular defects in rare bleeding disorders: hereditary haemorrhagic telangiectasia. Thromb Haemost 78:145–150
Weber FP (1907) Multiple hereditary development angioma-ta (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet ii:160-162
Hereditary Benign Telangiectasia
Gold MH, Eramo L, Prendiville JS (1989) Hereditary benign telangiectasia. Pediatr Dermatol 6:194–197
Puppin D, Rybojad M, Morel P (1992) Hereditary benign telangiectasia: two case reports. J Dermatol 19:384–386
Ryan TJ, Wells RS (1971) Hereditary benign telangiectasia. Trans St John’s Hosp Dermatol Soc 57:148–156
Zahorcsek Z, Schneider I (1994) Hereditary benign telangiectasia. Dermatology 189:286–288
Generalized Essential Telangiectasia
Checketts SR, Burton PS, Bjorkman DJ et al. (1997) Generalized essential teleangiectasia in the presence of gastrointestinal bleeding. J Am Acad Dermatol 37:321–325
Driban NE (1982) Progressive essentielle Teleangiektasien. Hautarzt 35:500–501
McGrae JD Jr, Winkelmann RK (1963) Generalized essential teleangiectasiae. JAMA 185:909–913
Shelley WB (1971) Essential progressive teleangiectasia: suc-cessfull treatment with tetracycline. JAMA 216:1343–1344
Unilateral Nevoid Telangiectasia
Hynes LR, Shenefelt PD (1997) Unilateral nevoid telangiectasia: occurence in two patients with hepatitis C. J Am Acad Dermatol 36:819–822
Taskapan O, Harmanyeri Y (1998) Acquired unilateral nevoid telangiectasia syndrome. J Am Acad Dermatol 39:138’139
Tok J, Berberian BJ, Sulica VI (1994) Unilateral nevoid telangiectasia syndrome. Cutis 53:53–54
Angioma Serpiginosum
Cox NH, Paterson WD (1991) Angioma serpiginosum: a simulator of purpura. Postgrad Med J 67:1065–1066
Gerbig AW, Zala L, Hunziker T (1995) Angioma serpiginosum, eine Hautveränderung entlang den Blaschko-Linien? Hautarzt 46:847–849
Long CC, Lanigan SW (1997) Treatment of angioma serpiginosum using a pulsed tunable dye laser. Br J Dermatol 136:631–632
Erythromelanosis Colli
Hellwig S, Schonermark M, Raulin C (1995) Treatment of vascular malformations and pigment disorders of the face and neck by pulsed dye laser, Photoderm VL and Q-switched ruby laser. Laryngorhinootologie 74:635–641
Schroeter CA, Neumann HA (1998) An intense light source. The photoderm VL-flashlamp as a new treatment possibility for vascular skin lesions. Dermatol Surg 24:743–748
Nevus Araneus
Enta T (1994) Dermacase. Nevus araneus (spider telangiectasia). Can Fam Physician 40:1105–1112
Venous Ectasias
Wiek K, Vanscheidt W, Ishkanian S et al. (1996) Selektive Photothermolyse von Besenreiservarizen und Teleangiektasien der unteren Extremität. Hautarzt 47:258–263
Functional Angiopathies. Acrocyanosis
Davis E (1992) Oscillometry of radial artery in acrocyanosis and cold sensitivity. J Mal Vasc 17:214–217
Hoegl L, Thoma-Greber E, Poppinger J et al. (1999) Butyl nitrite-induced acrocyanosis in an HIV-infected patient. Arch Dermatol 135:90–91
Mangiafico RA, Malatino LS, Santonocito M et al. (1996) Plasma endothelin-i concentrations during cold exposure in essential acrocyanosis. Angiology 47:1033–1038
Livedo Reticularis
Choi HJ, Hann SK (1999) Livedo reticularis and livedoid vasculitis responding to PUVA therapy. J Am Acad Dermatol 40:204–207
Gould JW, Helms SE, Schulz SM et al. (1998) Relapsing livedo reticularis in the setting of chronic pancreatitis. J Am Acad Dermatol 39:1035–1036
Morell A, Botella R, Silvestre JF et al. (1996) Livedo reticularis and thrombotic purpura related to the use of diphenhydramine associated with pyrithyldione. Dermatology 193:50–51
Nonaka Y, Sibue K, Shimizu A et al. (1997) Lipo-prostaglan-din E1 therapy for livedo reticularis with ulceration. Acta Derm Venereol (Stockh) 77:246–247
Erythromelalgia
Davis MDP, O’Fallon WM, Rogers RS et al. (2000) Natural history of erythromelalgia. Arch Dermatol 136:330–336
Drenth JP, Michiels JJ (1992) Clinical characteristics and pathophysiology of erythromelalgia and erythermalgia. Am J Med 93:111–114
Kalgaard OM, Seem E, Kvernebo K (1997) Erythromelalgia: a clinical study of 87 cases. J Intern Med 242:191–197
Michiels JJ, Drenth JP, Van Genderen PJ (1995) Classification and diagnosis of erythromelagia and erythermalgia. Int J Dermatol 34:97–100
Mørk C, Kvernebo K (2000) Eryhtromelalgia — a mysterious condition? Arch Dermatol 136:406–409
Rudikoff D, Jaffe IA (1997) Erythromelalgia: response to serotonin reuptake inhibitors. J Am Acad Dermatol 37: 281–283
Burning Feet Syndrome
Galer BS, Lipton RB, Kaplan R et al. (1991) Bilateral burning foot pain: monitoring of pain, sensation, and autonomic function during successful treatment with sympathetic blockade. J Pain Symptom Manage 6:92–97
Stogbauer F, Young P, Kuhlenbaumer G et al. (1999) Autosomal dominant burning feet syndrome. J Neurol Neuro-surg Psychiatry 67:78–81
Restless Legs Syndrome
Ekbom KA (1945) Restless legs. A clinical study of a hitherto overlooked disease in the legs characterized by peculiar paresthesia (“anxietas tibarum”), pain and weakness and occurring in two main forms, asthenia crurum parasthe-tica and asthenia crurum dolorosa. A short review of parasthesias in general. Acta Med Scand [Suppl] 158:1–123
Metcalfe RA, MacDermott N, Chalmers RJ (1986) Restless red legs: an association of the restless legs syndrome with arborizing telangiectasia of the lower limbs. J Neurol Neurosurg Psychiatry 49 (7): 820–823
Reflex Sympathetic Dystrophy
Faria SH, Flannary JC (1998) Reflex sympathetic dystrophy syndrome: an update. J Vasc Nurs 16:25–30
Kurvers HA (1998) Reflex sympathetic dystrophy: facts and hypothesis. Vasc Med 3:207–214
Nath RK, Mackinnon SE, Stelnicki E (1996) Reflex sympathetic dystrophy. The controversy continues. Clin Plast Surg 23:435–446
Sudeck P (1900) Über die akute entzündliche Knochenatrophie. Arch Klin Chir 62:147–156
Raynaud Syndrome and Raynaud Disease
Creutzig A, Caspary L, Freund M (1996) The Raynaud phenomenon and interferon therapy. Ann Intern Med 125:423
Gasbarrini A, Serricchio M, Tondi P et al. (1996) Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet 348:966–967
Maricq HR, Valter I, Maricq JG (1998) An objective method to estimate the severity of Raynaud phenomenon: digital blood pressure response to cooling. Vasc Med 3:109–113
Raynaud AG (1862) De Pasphyxie locale et la gangrene symetrique des extremites. Paris (Thesis)
Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600
Vergon JM, Barthelemy JC, Riffat J et al. (1992) Raynaud’s phenomenon of the lung. A reality both in primary and secondary Raynaud syndrome. Chest 101:1312–1317
Cutaneous Emboli
Watsky KL (1995) Sporotrichoid nodules in an immunocompromised host. Cutaneous emboli of Fusarium. Arch Dermatol 131:1329–1330
Watsky KL, Eisen RN, Bolognia JL (1990) Unilateral cutaneous emboli of Aspergillus. Arch Dermatol 126:1214–1217
Fat Emboli
Richards RR (1997) Fat embolism syndrome. Can J Surg 40:334–339
Vedrinne JM, Guillaume C, Gagnieu MC (1991) Diagnosis of fat emboli. Ann Intern Med 114:339
Cholesterol Emboli
Becker KA, Schwartz RA, Rothenberg J (1997) Leg ulceration and the cholesterol embolus. J Med 28: 387–392
Bell SP, Frankel A, Brown EA (1997) Cholesterol emboli syndrome — uncommon or unrecognized? J R Soc Med 90:543–546
Peat DS, Mathieson PW (1996) Cholesterol emboli may mimic vasculitis. BMJ 313:546–547
Rumpf KW, Schult S, Mueller GA (1998) Simvastin treatment in cholesterol emboli syndrome. Lancet 352:321–322
Vasculitis
Bacon PA (1993) Systemic vasculitic syndromes. Curr Opin Rheumatol 5:5–10
Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192
Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337:1512–1523
Jorizzo JL (1993) Classification of vasculitis. J Invest Dermatol 100:106S-110S
Schellong MS, Niedermeyer J, Bernhards J et al. (1993) Problems of classification in necrotizing vasculitis. Adv Exp Med Biol 336:345–348
Large Vessel Vasculitis. Giant Cell Arteritis
Dummer W, Zillikens DJ, Schulz A et al. (1996) Scalp necrosis in temporal (giant cell) arteritis: implications for the dermatologie surgeon. Clin Exp Dermatol 21:154–158
Horton BT, Magath TB, Brown GE (1932) An undescribed form of arteritis of the temporal vessels. Proc Staff Meet Mayo Clin 7:700–701
Karanjia ND, Cawthorn SJ, Giddings AE (1993) The diagnosis and management of arteriitis. J R Soc Med 86:267–270
Polymyalgia Rheumatica
Salvarani C, Macchioni P, Boiardi L (1997) Polymyalgia rheumatica. Lancet 350:43–47
Swannel AJ (1997) Polymyalgia rheumatica and temporal arteritis: diagnosis and management. Br Med J 314:1329–1332
Takayasu Arteritis
Hall S, Barr W, Lie JT (1985) Takayasu arteritis. A study of 32 North American patients. Medicine 64:89–99
Procter CD, Hollier LH (1992) Takayasu’s arteritis and temporal arteritis. Ann Vasc Surg 6:195–198
Schwarz-Eywill M, Breitbart A, Csernok E et al. (1993) Treatment modalities and ANCA in Takayasu’s arteritis. Adv Exp Med Biol 336:497–501
Takayasu M (1908) A case of strange anastomosis of the central vessels of the retina. J Jpn Ophthalmol Soc 12:554
Medium-Sized Vessel Vasculitis. Polyarteritis Nodosa and Cutaneous Polyarteritis Nodosa
Callen JP (1993) Cutaneous vasculitis and other neutrophilic dermatoses. Curr Opin Rheumatol 5:33–40
Daoud MS, Hutton, KP, Gibson LE (1997) Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 136:706–713
Fisher I, Orkin M (1964) Cutaneous form of periarteritis nodosa — an entity? Arch Dermatol 89:180–189
Fortin PR, Larson MG, Watters AK et al. (1995) Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group — a review of 45 cases. J Rheumatol 22:78–84
Guillevin L, Lothe F (1998) Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 41:2100–2105
Guillevin L, Lhote F, Amouroux J et al. (1996) Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis nodosa group. Br J Rheumatol 35:958–964
Kussmaul A, Maier R (1866) Über eine bisher nicht beschriebene eigentümliche Arterienerkrankung (Perarteriitis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Deut Arch Klin Med 1:484–518
Langford CA, Sneller MC (1997) New developments in the treatment of Wegener’s granulomatosis, polyarteritis nodosa, microscopic polyangitis, and Churg-Strauss syndrome. Curr Opin 9:26–30
Lindberg K (1931) Ein Beitrag zur Kenntnis der Periarteriitis nodosa. Acta Med Scand 76:183
Moreland LW, Ball GV (1990) Cutaneous Polyarteriitis nodosa. Am J Med 88:426–430
Sheth AP, Olson JC, Esterly NB (1994) Cutaneous polyarteritis nodosa of childhood. J Am Acad Dermatol 31:561–566
Kawasaki Disease
Barron KS, Shulman ST, Rowley A et al. (1999) Report of the National Institutes of Health Workshop on Kawasaki Disease. J Rheumatol 26:170–190
Chung CJ, Stein L (1998) Kawasaki disease: a review. Radiology 208:25–33
Hall M, Hoyt L, Ferried P et al. (1999) Kawasaki syndromelike illness associated with infection caused by entero-toxin B-secreting Staphylococcus aureus. Clin Infect Dis 29:386–389
Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children, [in Japanese] Arerugi 16:178–222
Leung DY, Meissner C, Fulton D et al. (1995) The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol 15 (6): 11–17
ANCA-Positive Small Vessel Vasculitis
Hagen EC, Ballieux BE, van Es LA et al. (1993) Antineutrophil cytoplasmatic autoantibodies; a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood 81:1996–2002
Niles JL (1996) Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Annu Rev Med 47:303–313
Wegener Granulomatosis
Duna GF, Galperin C, Hoffman GS (1995) Wegener’s granulomatosis. Rheum Dis Clin North Am 21:949–986
Hoffman GS (1993) Wegener’s granulomatosis. Curr Opin Rheumatol 5:11–17
Jennings CR, Jones NS, Dugar J et al. (1998) Wegener’s granulomatosis — a review of diagnosis and treatment in 53 subjects. Rhinology 36:188–191
Klinger H (1931) Grenzformen der Periarteriitis nodosa. Frankf Zschr Pathol 42:455–480
Knight JM, Hayduk MJ, Summerlin D-J et al. (2000) “Strawberry” gingival hyperplasia. Arch Dermatol 136:171–173
Lynch JP, Hoffman GS (1998) Wegener’s granulomatosis: controversies and current concepts. Comp Ther 24: 421–440
Reinhold-Keller E, Kekow J, Schnabel A et al. (1994) Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclo-phophamide therapy in patients with Wegener’s granulomatosis. Arthritis Rheum 37:919–924
Wegener F (1939) Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Path Anat 102:36–68
Churg-Strauss Syndrome
Bottero P, Venegoni E, Riccio G et al. (1990) Churg-Strauss syndrome. J R Soc Med 83:651–652
Behrens R, Holzhausen HJ, von Poblozki A et al. (1998) Eosinophil cationic protein in a 39-year-old patient with Churg-Strauss syndrome. Dtsch Med Wochenschr 123:6–11
Churg J, Strauss L (1951) Allergic granulomatosus, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277–294
Davis NDP, Dauod MS, McEvoy MT et al. (1997) Cutaneous manifestations of Chùrg-Strauss syndrome: a clinico-pathologic correlation. J Am Acad Dermatol 37:199–203
Masi AT, Hunder GG, Lie JT et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1101
Vogel PS, Nemer J, Sau P (1992) Churg-Strauss syndrome. J Am Acad Dermatol 27:821–824
Microscopic Polyangiitis
Davson J, Ball J, Platt R (1948) The kidney in periarteritis nodosa. QJ Med 17:175–202
Guillevin L, Durand-Gasselin B, Cevallos R et al. (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430
Irvine AD, Bruce IN, Walsh MY et al. (1997) Microscopic polyangiitis. Delineation of a cutaneous-limited variant associated with antimyeloperoxidase autoantibody. Arch Dermatol 133:474–477
Penas PF, Porras JI, Fraga J et al. (1996) Microscopic polyangiitis. A systemic vasculitis with a positive P-ANCA. Br J Dermatol 134:542–547
Zeek PM (1948) Studies on periarteritis nodosa. III. The differential between the vascular lesions of periarteritis nodosa and of hypersensitivity. Am J Pathol 24:889–917
Lymphomatoid Granulomatosis
Bekassy AN, Cameron R, Garwicz S et al. (1990) Lymphomatoid granulomatosis in children. J Rheumatol 17: 571–572
Liebow AA, Carrington CR, Friedman PJ (1972) Lymphomatoid granulomatosis. Hum Pathol 3:457–558
Magro CM, Tawfik NH, Crowson AN (1994) Lymphomatoid granulomatosis. Int J Dermatol 33:157–160
Tong MM, Cooke B, Barnetson RStC (1992) Lymphomatoid granulomatosis. J Am Acad Dermatol 27:872–876
Leukocytoclastic Angiitis
Abe Y, Tanaka Y, Takenaka M et al. (1997) Leucocytoclastic vasculitis associated with mixed cryoglobulinaemia and hepatitis C virus infection. Br J Dermatol 136:272–274
Gaudy A (1998) Pathogenesis of leukocytoclastic vasculitis. Eur J Dermatol 8:75–79
Gougerot H (1932) Septicémie chronique indéterminée caractériseé par de petits nodules dermique (“dermatitis nodularis non necroticans”), éléments érythémo-papu-leux, purpura. Bull Soc Fr Dermatol Syph 39:1192–1194
Jennette JC, Tuttle R, Falk RJ (1993) The clinical, serologic, and immunopathologic heterogeneitiy of cutaneous leukocytoclastic angiitis. Adv Exp Med Biol 336:323–326
Papi M, De Pita O, Frezzolini A et al. (1999) Prognostic factors in leukocytoclastic vasculitis: what is the role of antineutrophil cytoplasmic antibody? Arch Dermatol 135:714–715
Ruiter M, Brandsma CH (1948) Arteriolitis allergica. Dermatologica 97:265–271
Sais G, Vidaller A, Jucgla A et al. (1997) Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients. Arch Dermatol 133:443–450
Henoch-Schönlein Purpura
Baselga E, Drolet BA, Esterly NB (1997) Purpura in infants and children. J Am Acad Dermatol 37:673–705
Henoch H (1868) Über den Zusammenhang von Purpura und Intestinalstörungen. Berlin Klin Wochenschr 5: 517–519
Kraft DM, McKee D, Scott C (1998) Henoch-Schönlein purpura: a review. Am Farn Physician 58:405–408
Lanzkowsky S, Lanzkowsky L, Lanzkowsky P (1992) Henoch-Schönlein purpura. Pediatr Rev 13:130–137
Schönlein JL (1832) Allgemeine und spezielle Pathologie und Therapie. Etinger, Würzburg
Acute Hemorrhagic Edema
Finkelstein H (1938) Lehrbuch der Säuglings Krankheiten, 4th edn. Auff, Amsterdam, pp 814–830
Ince E, Mumcu Y, Suskan E et al. (1995) Infantile acute hemorrhagic edema: a variant of leucocytoclastic vasculitis. Pediatr Dermatol 12:224–227
Long D, Helm KL (1998) Acute hemorrhagic edema of infancy: Finkelstein’s disease. Cutis 61:283–284
Seidlmayer H (1940) Die früchtinfantile, postinfektiose Kokarden-Purpura. Zschr Kinderheilk 61:217–255
Serna MJ, Leache A, Sola MA (1994) Targetlike lesions in an infant. Infantile acut hemorrhagic edema (AHE). Arch Dermatol 130:1055–1059
Snow IM (1913) Purpura, urticaria and angioneurotic edema of the hands and feet in a nursing baby. JAMA 61:18–19
Urticarial Vasculitis
Black AK, Lawlor F, Greaves MW (1996) Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 21:424–426
Eads TJ, Fretzin S, Lewis C (1998) Pruritic, painful eruption. Urticarial vasculitis. Arch Dermatol 134:231–234
Hamid S, Cruz PD Jr, Lee WM (1998) Urticarial vasculitis caused by hepatitis C virus infection: response to interferon alpha therapy. J Am Acad Dermatol 39:278–280
McDuffie FC, Sams WM Jr, Maldonado JF (1973) Hypo-complimentemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc 48:340–348
Mehregan DR, Gibson LE (1998) Pathophysiology of urticarial vasculitis. Arch Dermatol 134:88–89
Papadavid E, Yu RC, Tay A et al. (1996) Urticarial vasculitis induced by centrally acting appetite suppressants. Br J Dermatol 134:990–991
Schnitzler Syndrome
de Kleijn EM, Telgt D, Laan R (1997) Schnitzler’s syndrome presenting as fever of unknown origin (FUO). The role of cytokines in its systemic features. Nether J Med 51: 140–142
Puddu P, Cianchini G, Girardelli CR et al. (1997) Schnitzler’s syndrome: report of a new case and review of the literature. Clin Exp Rheumatol 15:91–95
Schnitzler L, Schubert B, Boasson J et al. (1974) Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenstrom? Bull Soc Dermatol Syphil 81:363
Tomkova H, Shirafuji Y, Arata J (1998) Schnitzler’s syndrome versus adult onset Stall’s disease. Eur J Dermatol 8:118–121
Hypergammaglobulinemic Purpura (Waldenstrom)
Finder KA, McCollough ML, Dixon SL et al. (1990) Hypergammaglobulinemic purpura of Waldenstrom. J Am Acad Dermatol 23:669–676
Katayama J (1995) Clinical analysis of recurrent hypergammaglobulinemic purpura associated with Sjogren syndrome. J Dermatol 22:186–190
Senecal JL, Chartier S, Rothfield N (1995) Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indometacin and hydroxychloroquine. J Rheumatol 22:868–875
Waldenstrom J (1943) Zwei interessante Fälle mit Hyper-globulinämie. Schweiz Med Wochenschr 78:927
Yamamoto T, Yokohama A (1997) Hypergammaglobulinemic purpura associated with Sjogren’s syndrome and chronic C type hepatitis. J Dermatol 24:7–11
Tumor-Associated Vasculitis
Carson’s S (1997) The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol 24:360–372
Kurzrock R, Cohen PR (1993) Vasculitis and cancer. Clin Dermatol 11:175–187
Maestri A, Malacarne P, Santini A (1995) Henoch-Schönlein syndrome associated with breast cancer. A case report. Angiology 46:625–627
Nashitz JE, Yeshurun D, Eldar S et al. (1996) Diagnosis of cancer-associated vascular disorders. Cancer 77:1759–1767
Stashower ME, Rennie TA, Turiansky GW et al. (1999) Ovarian cancer presenting as leukocytoclastic vasculitis. J Am Acad Dermatol 40:287–289
Nodular Vasculitis
Cho KH, Lee DY, Kim CW (1996) Erythema induratum of Bazin. Int J Dermatol 35:802–808
Degitz K, Messer G, Schirren H et al. (1993) Successful treatment of erythema induratum of bazin following rapid detection of mycobacterial DNA by polymerase chain reaction. Arch Dermatol 129:1619–1620
Ollert MW, Thomas P, Körting HC et al. (1993) Erythema induratum of Bazin. Evidence of T-lymphocyte hyper-responsiveness to purified protein derivative of tuberculin: report of two cases and treatment. Arch Dermatol 129:469–473
Sanz-Vico MD, De Diego V, Sanchez Yus E (1993) Erythema nodosum versus nodular vasculitis. Int J Dermatol 32:108–112
Inflammatory Bowel Disease — Associated Vasculitis
Magro CM, Crowson AN (1999) A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol 21:234–240
Salmi M, Jalkanen S (1998) Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 4: 149–156
Erythema Elevatum Diutinum
Bachmeyer C, Aractingi S (1996) Erythema elevatum diutinum with HIV-2 infection. Lancet 347:1041–1042
LeBoit PE, Cockerell CJ (1993) Nodular lesions of erythema elevatum diutinum in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 28:919–922
Orteu CH, McGregor JM, Whittaker SJ et al. (1996) Erythema elevatum diutinum and Crohn disease: a common pathogenic role for measles virus? Arch Dermatol 132: 1523–1525
Radcliffe-Crocker H, Williams C (1894) Erythema elevatum diutinum. Brit J Dermatol 6:1–9
Sangueza OP, Pilcher B, Martin-Sangueza J (1997) Erythema elevatum diutinum: a clinicopathological study of eight cases. Am J Dermatopathol 19:214–222
Urbach E, Epstein E, Lorenz K (1932) Extrzelluläre Choles-terinose. Arch Dermatol Syph 166:243–272
Yiannis JA, El-Azhary RA, Gibson LE (1992) Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol 26:38–44
Pyoderma Gangrenosum
Brunsting LA, Goeckerman WH, O’Leary PA (1930) Pyoderma (ecthyma) gangrenosum, clinical and experimental observations in five cases occurring in adults. Arch Dermatol 22:655–680
Callen JP (1998) Pyoderma gangrenosum. Lancet 351:581–585
Chow RK, Ho VC (1996) Treatment of pyoderma gangrenosum. J Am Acad Dermatol 34:1047–1060
Dourmishev AL, Miteva I, Schwartz RA (1996) Pyoderma gangrenosum in childhood. Cutis 58:257–262
Ko CB, Walton S, Wyatt EH (1992) Pyoderma gangrenosum: associations revisited. Int J Dermatol 31:574–577
Long CC, Jessop J, Young M et al. (1992) Minimizing the risk of postoperative pyoderma gangrenosum. Br J Dermatol 127:45–48
Perry HO, Winkelmann RK, Muller SA et al. (1968) Malignant pyodermas. Arch Dermatol 98:561–576
Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34:395–409
Livedo Racemosa
Asherson RA, Cervera R (1993) Antiphospholipid syndrome. J Invest Dermatol 100:21S–27S
Zala L, Braathen LR (1994) Livedo racemosa: a report of five cases. Dermatology 189:421–424
Sneddon Syndrome
Alegre VA, Winkelmann RK, Gastineau DA (1990) Cutaneous thrombosis, cerebrovascular thrombosis, and lupus anticoagulant — the Sneddon syndrome. Report of 10 cases. Int J Dermatol 29:45–49
Daoud MS, Wilmoth GJ, Su WP et al. (1995) Sneddon syndrome. Semin Dermatol 14:166–172
Schellong SM, Weissenborn K, Niedermeyer J et al. (1997) Classification of Sneddon’s syndrome. Vasa 26:215–221
Sneddon IB (1965) Cerebrovascular lesions and livedo reticularis. Brit J Derm 77:80–85
Zeiger B, Sepp N, Stockhammer G et al. (1993) Sneddon’s syndrome. A long-term follow-up of 21 patients. Arch Dermatol 129:437–447
Livedo Vasculitis
Feldaker M, Hines EA Jr, Kierland RR (1955) Livedo reticularis with summer ulcerations. Arch Dermatol 72:31–42
Cutis Marmorata Telangiectatica Congenita
Baxter P, Gardner-Medwin D, Green SH et al. (1993) Congenital livedo reticularis and recurrent stroke-like episodes. Dev Med Child Neurol 35:917–921
Lohuizen CH, van (1922) Über eine seltene angeborene Hautanomalie (Cutis marmorata Telangiectactica). Acta Derm Venereol (Stockh) 3:202–211
Picascia DD, Esterly NB (1989) Cutis marmorata teleangiectatica congenita: report of 22 cases. J Am Acad Dermatol 20:1098–1104
Rupprecht R, Hundeiker M (1997) Cutis marmorata teleangiectatica congenita. Hautarzt 48:21–25
Wheeler PG, Medina S, Dusik A et al. (1998) Livedo reticularis, developmental delay and stroke-like episode in a 7-year-old male. Clin Dysmorphol 7:69–74
Malignant Atrophic Papulosis
Assier H, Chosidow O, Piette JC et al. (1995) Absence of antiphospholipid and anti-endothelial cell antibodies in malignant atrophic papulosis: a study of 15 cases. J Am Acad Dermatol 33:831–833
Degos R, Delort J, Tricot R (1942) Dermatite papulosqua-meuse atrophiante. Ann Dermatol Syph 21:148–150
Katz SK, Mudd LJ, Roenigk HH (1997) Malignant atrophic papulosis (Dego’s disease) involving three generations of a family. J Am Acad Dermatol 37:480–484
Köhlmeier W (1940) Multiple Hautnekrosen bei Thromboangiitis obliterans. Arch Dermatol 181:783–792
Snow JL, Muller SA (1995) Degos syndrome: malignant atrophic papulosis. Semin Dermatol 14:99–105
Yag-Howard C, Shenefelt PD (1998) Multiple pink papules with white, depressed centers. Malignant atrophic papulosis (Degos disease). Arch Dermatol 134:233–236
Peripheral Occlusive Arterial Disease
Altstaedt HO, Berzewski B, Taschke (1993) Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids 49:573–578
Horsch S, Claeys L (1994) Epidural spinal cord stimulation in the treatment of severe peripheral arterial occlusive disease. Ann Vasc Surg 8:468–474
LoGerfo FW (1992) Peripheral arterial occlusive disease and the diabetic: current clinical management. Heart Dis Stroke 1:395–397
McCulloch JM, Kemper CC (1993) Vacuum-compression therapy for the treatment of an ischemic ulcer. Phys Ther 73:165–169
Pemberton M, London NJ (1997) Colour flow duplex imaging of occlusive arterial disease of the lower limb. Br J Surg 84:912–919
Diabetic Angiopathy
Bierhaus A, Ziegler R, Nawroth PP (1998) Molecular mechanisms of diabetic angiopathy — clues for innovative therapeutic interventions. Horm Res 50:1–5
Stehouer CD, Lambert J, Donker AJ et al. (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34:55–68
Tooke JE, Shore AC, Cohen RA et al. (1996) Diabetic angiopathy: tracking down the culprits. J Diabetes Complications 10:173–181
Thrombangiitis Obliterans
Buerger L (1908) Thromangiitis obliterans: a study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med 136:567–580
Mishima Y (1996) Thromangiitis obliterans (Buerger’s disease). Int J Cardiol 54: S185–187
Suzuki S, Yamada I, Himeno Y (1996) Angiographic findings in Buerger disease. Int J Cardiol 54: S189–195
Zellerman GL, Lin MT, Rosen T (1998) Chronic ulcerations in the upper and lower extremities. Thrombangiitis obliterans (Buerger disease). Arch Dermatol 134:1019–1023
Hypertensive Ulcer
Henderson CA, Highet AS, Lane SA et al. (1995) Arterial hypertension causing leg ulcers. Clin Exp Dermatol 20: 107–114
Martorell F (1945) Las úlceras supramaleolares por arterio-litis de los grandes hipertensos. Actas Inst Policlinico (Barcelona) 1:6–9
Nikolova K (1995) Treatment of hypertensive venous leg ulcers with nifedipine. Methods Find Exp Clin Pharmacol 17:545–549
Diseases of the Veins
Kappert A (1998) Lehrbuch und Atlas der Angiologie, 13th edn. Huber, Bern
Rabe E (1994) Grundlagen der Phlebologie. Kagerer Kommunikation, Bonn
Ramelet AA, Monti M (1999) Phlebology. Elsevier, Amsterdam
Ruckley CV, Fowkes FGR, Bradbury AW (eds) (1999) Venous disease, epidemiology, management and delivery of care. Springer, London
Tibbs DJ, Sabiston DC, Davies MG et al. (eds) (1997) Varicose veins, venous disorders, and lymphatic problems in the lower limbs. Oxford University Press, Oxford
Wienert V (1993) Beinveneninsuffizienz, 2nd edn. Schattauer, Stuttgart
Varicosities
De Roos KP, Neumann HA (1998) Muller’s ambulatory phlebectomy for varicose veins of the foot. Dermatol Surg 24:465–470
Evans CJ, Fowkes FG, Hajivassiliou CA et al. (1994) Epidemiology of varicose veins. A review. Int Angiol 13: 263–270
Goldman MP, Weiss RA, Bergan JJ (1994) Diagnosis and treatment of varicose veins: a review. J Am Acad Dermatol 31:393–413
Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, teleangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg 21:19–29
Morrow PL, Hardin NJ, Karn CM et al. (1994) Fatal hemorrhage by varicose veins. Am J Forensic Med Pathol 15: 100–104
Palfreyman SJ, Lochiel R, Michaels JA (1998) A systemic review of compression therapy for venous leg ulcers. Vase Med 3:301–313
Smith SR, Goldman MP (1998) Tumescent anesthesia in ambulatory phlebectomy. Dermatol Surg 24:453–456
Thrombophlebitis
Bergqvist D, Jaroszewski H (1986) Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. Br Med 1292:658–659
Campbell B (1996) Thrombitis, phlebitis, and varicose veins. Br Med J 312:198
Guex JJ (1996) Thrombotic complications of varicose veins. A literature review of the role of superficial venous thrombosis. Dermatol Surg 22:378–382
Superficial Migratory Thrombophlebitis
Fiehn C, Pezzuto A, Hunstein W (1994) Superficial migratory thrombophlebitis in a patient with reversible protein C deficiency and anticardiolipin antibodies. Ann Rheum Dis 53:843–844
Vaughan MM, Thomas WE (1995) Thrombophlebitis migrans in association with acute relapsing pancreatitis. Br J Surg 82:674
Walsh-McMonagle D, Green D (1997) Low-molecular-weight heparin in the management of Trousseau’s syndrome. Cancer 80:649–655
Superficial Sclerosing Phlebitis
Chiedozi LC, Aghahowa JA (1988) Mondor’s disease associated with breast cancer. Surgery 103:438–439
Cox EM, Siegel DM (1997) Mondor disease: an unusual consideration in a young woman with a breast mass. J Ado-lesc Health 21:183–185
Favre JP, Becker F, Lorcerie B et al. (1992) Vascular manifestations in homocystinuria. Ann Vasc Surg 6:294–297
Diamantopoulos EJ, Yfanti G, Andreadis E (1999) Giant-cell arteritis presenting as Mondor disease. Ann Intern Med 130:78–79
Mondor H (1939) Tronculite souscutanée de la paroi thoracique antéro-laterale. Mem Acad Chir 65:1271–1278
Deep Vein Thrombosis
Bounameaux H, de Moerloose P, Perrier A et al. (1994) Plasma measurement of D-Dimer as a diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 71:1–6
Brandjes DPM, Büller H, Hejboer H et al. (1997) Incidence of the postthrombotic syndrome and the effects of compression stockings in patients with proximal venous thrombosis. Lancet 349:759–762
Cogo A, Lensing AWA, Koopman MMW et al. (1998) Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 316:17–20
Ginsberg JS (1996) Management of venous thromboembolism. N Engl J Med 335:1816–1828
Hirsh J, Weitz JI (1999) New antithrombotic agents. Lancet 353:1431–1436
Lensing AWA, Prandoni P, Prins MH et al. (1999) Deep vein thrombosis. Lancet 353:479–485
Martineau P, Tawil N (1998) Low-molecular-weight heparins in the treatment of deep-vein thrombosis. Ann Pharma-cother 32:588–598
Nordstrom M, Lindblad B, Anderson H et al. (1994) Deep venous thrombosis and occult malignancy: an epidemiological study. Br Med J 308:891–894
Partsch H, Kechavarz B, Köhn H et al. (1996) The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin. Int Angiol 16:189–192
Rosendaal FR (1999) Venous thrombosis: a multicausal disease. Lancet 353:1167–1173
Schulman S, Granqvist St, Holmström M et al. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336:393–398
Wheeler HB, Hirsch J, Wells P et al. (1994) Diagnostic tests for deep vein thrombosis. Arch Intern Med 154: 1921–1928
Diseases Associated with Hypercoagulability
Brigden ML (1997) The hypercoagulable state. Who, how, and when to test and treat. Postgrad Med 101:249–262
Girolami A, Simioni P, Scarano L et al. (1997) Venous and arterial thrombophilia. Haematologica 82:96–100
Milian G (1929) Les atrophies cutanées syphilitiques. Bull Soc Fr Dermatol 36:865–871
Nachman RL, Silverstein R (1993) Hypercoagulable states. Ann Intern Med 119:819–827
Rao AK, Sheth S, Kaplan R (1997) Inherited hypercoagulable states. Vasc Med 2:313–320
Rosenberg RD, Aird WC (1999) Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 340:1555–1564
van den Belt AG, Sanson BJ, Simioni P et al. (1997) Recurrence of venous thromboembolism in patients with familial thrombophilia. Arch Intern Med 157:2227–2232
Zoller B, Garcia de Frutos P, Hillarp A et al. (1999) Thrombophilia as a multigenic disease. Haematologica 84:59–70
Antithrombin III Deficiency
Demers C, Ginsberg JS, Hirsh J et al. (1992) Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med 116: 754–761
Rosendaal FR, Heijboer H (1991) Mortality related to thrombosis in congenital antithrombin III deficiency. Lancet 337:1545
Seguin J, Weatherstone K, Nankervis C (1994) Inherited antithrombin III deficiency in the neonate. Arch Pediatr Adolesc Med 148:389–393
Antithrombin III Deficiency
Aiach M, Gandrille S, Emmerich J (1995) A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost 74:81–89
Allaart CF, Poort SR, Rosendaal FR et al. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134–138
Amster MS, Conway J, Zeid M et al. (1993) Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus. J Am Acad Dermatol 29:853–857
Baccard M, Vignon-Pennamen MD, Janier M et al. (1992) Livedo vasculitis with protein C system deficiency. Arch Dermatol 128:1410–1411
Falanga V, Bontempo FA, Eaglstein WH (1990) Protein C and protein S plasma levels in patients with lipodermato-sclerosis and venous ulceration. Arch Dermatol 126: 1195–1197
Libow LF, DiPreta EA, Dyksterhouse DL (1997) Cutaneous heparin necrosis in a patient with heterozygous protein S deficiency. Cutis 59:242–244
Phillips WG, Marsden JR, Hill FG (1992) Purpura fulminans due to protein S deficiency following chickenpox. Br J Dermatol 127:30–32
Schramm W, Spannagl M, Bauer KA et al. (1993) Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate. Arch Dermatol 129:753–756
Weir Nu, Snowden JA, Greaves M et al. (1995) Livedo reticularis associated with hereditary protein C deficiency and recurrent thromboembolism. Br J Dermatol 132:283–285
Factor V Mutation
Bertina RM, Koeleman BPC, Koster T et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64–67
Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004–1008
Desmarais S, de Moerloose P, Reber G et al. (1996) Resistance to activated Protein C in an unselected population of patients with pulmonary embolism. Lancet 347:1374–1375
Hoerl HD, Tabares A, Kottke-Marchant K (1996) The diagnosis and clinical manifestations of activated protein C resistance: a case report and review of the literature. Vase Med 1:275–280
Munkvard S, Jorgensen M (1996) Resistance to activated protein C. A common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 134:296–298
Peus D, von Schmiedeberg S, Pier A et al. (1996) Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression. J Am Acad Dermatol 25:306–309
Zöller B, Dahlbäck B (1994) Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536–1538
Prothrombin Gene Mutation
De Stefano V, Martinelli I, Mannucci PM et al. (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G2021A prothrombin mutation. N Engl J Med 341:801–806
Martinelli I, Sacchi E, Landi G et al. (1998) High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 338:1793–1797
Poort SR, Rosendaal FR, Reitsma PH et al. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703
Homocystinuria
den Heijer M, Koster T, Blom HJ et al. (1996) Hyperhomocy-stinemia as a risk factor for deep vein thrombosis. N Engl J Med 334:759–762
Favre JP, Becker F, Lorcerie B et al. (1992) Vascular manifestations in homocystinuria. Ann Vase Surg 6:294–297
Makris M (1998) Hyperhomocystinemia is a risk factor for venous and arterial thrombosis. Br J Haematol 101:18–20
Mandel H, Brenner B, Beranet M et al. (1996) Coexistence of hereditary homocystinuria and factor V Leiden — effect on thrombosis. N Engl J Med 334:763–768
Chronic Venous Insufficiency
Anderson JH, Geraghty JG, Wilson YT et al. (1990) Paroven and graduated compression hosiery for superficial venous insufficiency. Phlebology 5:271–276
Cheatle TR, Scurr JH, Coleridge Smith PD (1991) Drug treatment of chronic venous insufficiency and venous ulceration: a review. J R Soc Med 84:354–358
Dunn JM, Cosford EJ, Kernick VFM et al. (1995) Surgical treatment for venous ulcers: is it worthwhile? Ann R Coll Surg Engl 77:421–424
Goren G (1991) Injection sclerotherapy for varicose veins: history and effectiveness. Phlebology 6:7–11
Groen G, Yellin AE (1995) Minimally invasive surgery for primary varicose veins: limited invaginated axial stripping and tributary (hook) stab avulsion. Ann Vase Surg 9:401–414
Kistner RL (1997) Classification of chronic venous disease. Vasc Surg 3:217–218
Leu HJ (1993) Morphological findings in chronic venous insufficiency. Phlebology 8:48–49
Leu AJ, Leu HJ, Franzeck UK et al. (1995) Microvascular changes in chronic venous insufficiency — a review. 3:237–245
Lynch TG, Dalsing MC, Ouriel K et al. (1999) Developments in diagnosis and classification of venous disorders: non-invasive diagnosis. Cardiovasc Surg 7:160–178
Motykie GD, Caprini JA, Arcelus JI et al. (1999) Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg 25:116–120
Oesch A (1993) ‘Pin-stripping’: a novel method of atraumatic stripping. Phlebology 8:171–173
Piller MH, Ernst E (1998) Horse-chestnut seed extract for chronic venous insufficiency. A criteria based systematic review. Arch Dermatol 134:1356–1360
Porter JM, Moneta GL (1995) International Consensus Committee on Chronic Venous Disease. Reporting standards in venous disease: an update. J Vase Surg 21:635–645
Widmer LK, Kamber V, Leu HJ (1978) Dokumentation und Einteilung. In: Widmer LK (ed) Venenkrankheiten: Häufigkeit und sozialmedizinische Bedeutung. Hans Huber Verlag, Bern, pp 17–32
Stasis Ulcer
Black SB (1995) Venous stasis ulcers: a review. Ostomy Wound Manage 41:20–30
Gosain A, Sanger JR, Yousif NJ et al. (1991) Basal cell carcinoma of the lower leg occuring in association with chronic venous stasis. Ann Plast Surg 26:279–283
Gourdin FW, Smith JG (1993) Etiology of venous ulceration. South Med J 86:1142–1146
Padberg FT (1999) Surgical intervention in venous ulceration. Cardiovasc Surg 7:83–90
Schmeller W, Gaber Y, Gehl H-B (1998) Shave therapy is a simple, effective treatment of persistent venous leg ulcers. J Am Acad Dermatol 39:232–238
Other Diseases Associated with Chronic Venous Deficiency Atrophie Blanche
Bisalbutra P, Kullavanijaya P (1993) Sulfasalazine in atrophie blanche. J Am Acad Dermatol 28:275–276
Cooper DL, Bolognia JL, Lin JT (1991) Atrophie blanche in a patient with gamma-heavy-chain disease. Arch Dermatol 127:272–273
Suarez SM, Palier AS (1993) Atrophie blanche with onset in childhood. J Pediatr 123:753–755
Acroangiodermatitis
Chaix A (1926) La dermite pigmentée et purpurique des membres inférieurs. Lésions pré-erosive des ulcères dits variqueux. Lyon (Thesis)
Favre M (1941) Nouvelle pratique dermatologique. Paris, p. 413
Landthaler M, Stolz W, Eckert F et al. (1989) Pseudo-Kaposfs sarcoma occurring after placement of arteriovenous shunt. J Am Acad Dermatol 21:499–505
Mali JWH, Kuiper JP, Hamers AA (1965) Acroangiodermatitis of the foot. Arch Dermatol 92:515
Rao B, Unis M, Poulos E (1994) Acroangiodermatitis: a study of ten cases. Int J Dermatol 33:179–183
Yi JU, Lee CW (1990) Acroangiodermatitis. A clinical variant of stasis dermatitis. Int J Dermatol 29:515–516
Postthrombotic Syndrome
Biguzzi E, Mozzi, Alatri A et al. (1998) The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost 80:575–577
Ernst E (1992) Rheology of the post-thrombotic syndrome. J Mal Vasc 17:93–96
Leizorovicz A (1998) Long-term consequences of deep vein thrombosis. Haemostasis 28:1–7
Prandoni P, Lensing AW, Cogo A et al. (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125:1–7
Rutherford RB (1996) Pathogenesis and pathophysiology of the post-thrombotic syndrome: clinical implications. Semin Vasc Surg 9:21–25
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braun-Falco, O., Plewig, G., Wolff, H.H., Burgdorf, W.H.C. (2000). Diseases of the Blood Vessels. In: Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97931-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-97931-6_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-97933-0
Online ISBN: 978-3-642-97931-6
eBook Packages: Springer Book Archive